BJSM

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 5 November 2007. doi:10.1136/bjsm.2007.041830
British Journal of Sports Medicine 2008;42:162
Copyright © 2008 BMJ Publishing Group Ltd & British Association of Sport and Exercise Medicine

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
bjsm.2007.041830v1
42/3/162    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lippi, G
Right arrow Articles by Cesare Guidi, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lippi, G
Right arrow Articles by Cesare Guidi, G

OCCASIONAL PIECES

Switch off the light on cycling, switch off the light on doping

G Lippi1, M Franchini2, G Cesare Guidi1

1 Sezione di Chimica Clinica, Dipartimento di Scienze Morfologico-Biomediche, Universitè di Verona, Italy
2 Servizio di Immunoematologia e Trasfusione, Azienda Ospedaliera di Verona, Italy

Correspondence to:
Professor G Lippi, MD, Sezione di Chimica Clinica, Dipartimento di Scienze Morfologico-Biomediche, Universitè degli Studi di Verona, Ospedale Policlinico GB Rossi, Piazzale Scuro, 10, 37134 Verona, Italy; ulippi@tin.it

The first 150 words of the full text of this article appear below.

There is rather a long history of fraud in sport competitions, and doping has plagued the Tour de France almost since its beginning in 1903, culminating on 13 July, 1967 with the dramatic death of British cyclist Tom Simpson on the climb of Mont Ventoux, attributed to the use of amphetamines and complicated by the now defunct practice of drinking as little as possible.1 Nearly a year after the 2006 "Tour de Chaos", when nine riders who were implicated in an international doping probe based on blood transfusions were ruled out of the race and the winner of the yellow jersey tested positive for testosterone,2 a sequence of events again plagued the 2007 competition. First, a German rider was tested non-negative for testosterone in an out-of-competition antidoping control a few days before the start of the race. Then, an Italian rider tested "non-negative" in a doping test for testosterone after . . . [Full text of this article]




This article has been cited by other articles:


Home page
CMAJHome page
A. Pipe MD Dip Spo and P. C. Hebert MD MHSc
Doping, sport and the community
Can. Med. Assoc. J., August 12, 2008; 179(4): 303 - 303.
[Full Text] [PDF]


Home page
CMAJHome page
A. Pipe MD dip. m& and P. C. Hebert MD MHSc
Le dopage, le sport et la communaute
Can. Med. Assoc. J., August 12, 2008; 179(4): 305 - 305.
[Full Text] [PDF]


Home page
Br Med BullHome page
G. Lippi, M. Franchini, and G. C. Guidi
Doping in competition or doping in sport?
Br. Med. Bull., June 1, 2008; 86(1): 95 - 107.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 BMJ Publishing Group Ltd & British Association of Sport and Exercise Medicine